Skip to content
Research Article Open access CC BY 3.0

Dextromethorphan for Tardive Dyskinesia

Jungjin Kim, James Donovan, Thomas L. Schwartz

International Neuropsychiatric Disease Journal · pp. 136–140 · Published 11 Feb 2014

10.9734/INDJ/2014/7970

Abstract

Aims: To report three cases of successful treatment of tardive dyskinesia (TD) with dextromethorphan. Study Design:  Retrospective chart review. Place and Duration of Study: Private outpatient practice in Syracuse, NY. Methodology: A retrospective chart review of patients with TD who were treated with dextromethorphan between 2003 and 2013 was conducted. Results: Three consecutive patients experienced marked improvement of TD with dextromethorphan. Conclusion: Dextromethorphan may be a useful drug for treating TD. Further prospective studies are needed.   

Tardive dyskinesia dextromethorphan dextromethorphan-quinidine

References (15)

  1. 1 Oxidative Mechanisms and Tardive Dyskinesia [DOI]
  2. 2 Dextromethorphan An Overview of Safety Issues [DOI]
  3. 3 Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation [DOI]
  4. 4 Review of Pseudobulbar Affect Including a Novel and Potential Therapy [DOI]
  5. 5 Role of Opioidergic and Serotonergic Mechanisms in Cough and Antitussives [DOI]
  6. 6 High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens [DOI]
  7. 7 A trial of dextromethorphan in parkinsonian patients with motor response complications [DOI]
  8. 8 Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan [DOI]
  9. 9 Anti‐dyskinetic mechanisms of amantadine and dextromethorphan in the 6‐OHDA rat model of Parkinson’s disease: role of NMDA vs. 5‐HT1A receptors [DOI]
  10. 10 Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N- in brain slices [DOI]
  11. 11 Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease [DOI]
  12. 12 Free radical mechanisms in schizophrenia and tardive dyskinesia [DOI]
  13. 13 Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.
  14. 14 Excitotoxic Mechanisms May Be Involved in the Pathophysiology of Tardive Dyskinesia [DOI]
  15. 15 Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex [DOI]

Cited by 3

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

22

Page views

0

PDF downloads

2

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.